Senior Program Manager, Gene Therapy Initiatives

Crispr Therapeutics Inc in; Boston (MA); Hybrid; USD 140,000 - 155,000; Full time

Benefits offered by this job

Remote work flexibility

On-site collaboration and mentorship

Job summary

CRISPR Therapeutics, Inc. is seeking a Senior Manager, Program Management in Boston to drive R&D program integration across discovery, preclinical, CMC, and clinical development.

You will lead cross-functional teams, develop strategic plans, and ensure on-time delivery of critical programs using robust project-management practices. The role requires a strong track record in preclinical and early clinical program management for biotechnology, with a scientific understanding of genome editing and

Qualifications

• Degree in the life sciences with 3-4+ years of program management experience managing cross-functional product development teams

Responsibilities

• Drives program teams and collaborates with Program Leader to manage operational aspects, strategy, and timelines
• Implements integrated program plans and tracks milestones and decision points
• Manages risk, contingencies, and issue resolution across functions
• Ensures cross-functional alignment and stakeholder management
• Represents program to Senior Management and aligns activities with corporate strategy

Skills

Program management

Cross-functional leadership

Meeting deadlines

Communication

Leadership

MS Project

Visio

ThinkCell

MS Timeline

MS Word

MS PowerPoint

MS Excel

Education

Bachelor's degree in life sciences

Advanced degree (MS/PhD)

Tools

MS Project

Visio

ThinkCell

MS Timeline

MS Word

MS PowerPoint

MS Excel

Job description

CRISPR Therapeutics, Inc. is seeking a Senior Manager, Program Management in Boston to drive R&D program integration across discovery, preclinical, CMC, and clinical development.

You will lead cross-functional teams, develop strategic plans, and ensure on-time delivery of critical programs using robust project-management practices. The role requires a strong track record in preclinical and early clinical program management for biotechnology, with a scientific understanding of genome editing and